<sup>225</sup>Ac在肿瘤靶向治疗中的应用及进展
锕-225(<sup>225</sup>Ac)具有高传能线密度、适宜的半衰期、短粒子射程和良好的配位能力等特性,是很有医用前景的α核素之一,在肿瘤的靶向放射性核素治疗中具有重要的研究价值。本文简要介绍了<sup>225</sup>Ac的物理和化学特性以及常用螯合剂(前列腺特异性膜抗原、奥曲肽、纳米载体等),围绕着以多肽或小分子为靶向分子、以单克隆抗体或蛋白为靶向分子和基于纳米载体的TAT药物,综述了<sup>225</sup>Ac标记的靶向药物在肿瘤中的应用和纳米材料对<sup>225</sup>A...
Saved in:
Main Authors: | 王立琴, 柳江燕 |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Sun Yat-sen University
2024-07-01
|
Series: | Zhongshan Daxue xuebao. Yixue kexue ban |
Subjects: | |
Online Access: | http://xuebaoyx.sysu.edu.cn/zh/article/doi/10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240617.007/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
抗肿瘤靶点研究及治疗策略
by: 江振友
Published: (2020-01-01) -
多功能纳米载体靶向传输 Survivin siRNA 抑制肝细胞癌增殖
by: 彭焘
Published: (2019-01-01) -
叶酸受体介导的载顺铂磁性纳米pH敏感药物的制备及性能
Published: (2014-01-01) -
分子靶向药物治疗肝细胞癌的研究进展
by: 王耀民, et al.
Published: (2023-11-01) -
Long-Term Therapeutic Effects of <sup>225</sup>Ac-DOTA-E[c(RGDfK)]<sub>2</sub> Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma
by: Mitsuyoshi Yoshimoto, et al.
Published: (2024-12-01)